Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide.

Jang M, Kim Y, Won H, Lim S, K R J, Dashdorj A, Min YH, Kim SY, Shokat KM, Ha J, Kim SS

DOI: 10.1158/0008-5472.can-12-1110
Published: 2012 Aug 15
Container: Cancer research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 37/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
cautionRetraction Watch correction: 1 correction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-12-1110,
  title = {Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide.},
  author = {Jang M and Kim Y and Won H and Lim S and K R J and Dashdorj A and Min YH and Kim SY and Shokat KM and Ha J and Kim SS},
  year = {2012},
  journal = {Cancer research},
  doi = {10.1158/0008-5472.can-12-1110},
  url = {https://doi.org/10.1158/0008-5472.can-12-1110}
}

RIS

TY  - JOUR
TI  - Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide.
AU  - Jang M
AU  - Kim Y
AU  - Won H
AU  - Lim S
AU  - K R J
AU  - Dashdorj A
AU  - Min YH
AU  - Kim SY
AU  - Shokat KM
AU  - Ha J
AU  - Kim SS
PY  - 2012
JO  - Cancer research
DO  - 10.1158/0008-5472.can-12-1110
UR  - https://doi.org/10.1158/0008-5472.can-12-1110
ER  -

APA

M, J., Y, K., H, W., S, L., J, K. R., A, D., YH, M., SY, K., KM, S., J, H., & SS, K. (2012). Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide.. Cancer research. https://doi.org/10.1158/0008-5472.can-12-1110

Source records

pubmed · retrieved 2026-09-26T05:16:14.884Z